Search Results 1861-1870 of 19551 for hemoglobin

1. A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR) - Mayo Clinic

   Hemoglobin (Hgb) at screening above gender-specific upper limit of normal (ULN), per local laboratory test. Baseline platelet count < 50,000/mm^3 (< 50.0 ...

2. Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) - Mayo Clinic

   ... hemoglobin and reticulocyte count are within the reference range of the sponsor-identified central laboratory. NOTE: If there is a > 50% variability between ...

3. Neurology - Clinical trials - Mayo Clinic

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

4. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone - Mayo Clinic

   Hemoglobin ≥ 10 g/dL;; Serum Creatinine < 2.0 mg/dL [176.8 µmol/liter];; Serum calcium ≤ 11.5 mg/dL;; Calc. Creatinine Clearance > 50 mL/min;; Bilirubin ...

5. Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) - Mayo Clinic

   Hemoglobin ≥ 8 g/dL;; Platelets ≥ 100,000/mm3 or 100 × 109/L. Have adequate hepatic function as evidenced by: Serum total bilirubin ≤2 × upper limit of ...

6. A Study of SGN-B7H4V in Advanced Solid Tumors - Mayo Clinic

   - Hemoglobin (Hgb) ≥ 9 g/dL;. - Platelet count ≥ 100,000/μL;. - Serum bilirubin ≤ 1.5 × upper limit of normal (ULN) or ≤ 3 × ULN for subjects with ...

7. Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer - Mayo Clinic

   Adequate hematologic counts without transfusion or growth factor support within 2 weeks of study drug initiation (hemoglobin ≥ 9 g/dL, absolute neutrophil ...

8. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

   - ELIGIBILITY CRITERIA (STEP 1): Hemoglobin >= 9 g/dL - ELIGIBILITY CRITERIA (STEP 1): Creatinine clearance (CrCl) >= 30 mL/min - ELIGIBILITY CRITERIA (STEP ...

9. Clinical Trial of Upfront Haploidentical or Unrelated Donor Bmt to Restore Normal Hematopoiesis in Aplastic Anemia

   Participation eligibility · Diffusing capacity of the lung for carbon monoxide (DLCO, corrected/adjusted for hemoglobin [Hb]) > 50%; · Spirometry with forced ...

10. A Study Evaluating Effectiveness and Safety of FFX Versus Combination of CPI-613 with mFFX in Patients with Metastatic Adenocarcinoma of the Pancreas - Mayo Clinic

    Hemoglobin ≥ 9 g/dL or ≥ 90 g/L). Adequate hepatic function: Aspartate aminotransferase [AST/SGOT] ≤ 3x upper normal limit [UNL] Alanine aminotransferase ...